Corporate Snapshot – Reploid (HRX5.VI)
Reploid traded flat over the most recent 24‑hour window that closed at 12:13 AM Central Europe on Friday 23 October 2026. The share price remains anchored at approximately EUR 1,490 on major exchanges, with a total supply of 110 000 shares and a market capitalisation of EUR 164 million. Trading activity over the last day was modest, with only about EUR 4.5 k of the stock changing hands.
Key Technical Indicators
- 200‑day Simple Moving Average: EUR 1,720.8
- 52‑Week High: EUR 2,000 (recorded 25 August 2026)
- 52‑Week Low: EUR 1,420 (recorded 8 October 2026)
Since the close of the previous month, Reploid’s equity has declined 4.49 %. Despite this short‑term dip, the long‑term trend remains bullish, supported by the firm’s solid earnings base and a stable liquidity profile.
Peer Performance (Last 24 Hours)
| Company | Symbol | % Change | Current Price (EUR) | Market Cap (EUR mn) | P/E Ratio |
|---|---|---|---|---|---|
| UBM Development | UBS.VI | –0.66 % | 14.50 | 109.9 | 581.71 |
| Steyr Motors | 4X0.DE | –1.66 % | 35.66 | 190.1 | 47.66 |
| Fit | FTG.VI | –12.46 % | 52.80 | 79.4 | – |
| Athos Immobilien | ATH.VI | +1.40 % | 43.60 | 75.4 | 379.52 |
| Frauenthal | FKA.VI | +2.80 % | 22.00 | 190.3 | 32.53 |
The performance spread across the sector underscores a fragmented market, with Reploid holding a relatively stable position amid volatility. Athos Immobilien and Frauenthal have exhibited modest gains, while Fit’s sharp decline signals sector‑specific headwinds that do not yet appear to encumber Reploid’s valuation.
Forward Outlook
Reploid’s current flat trading activity is a tactical pause rather than a warning. The 200‑day moving average provides a robust support level, and the proximity to the 52‑week low suggests ample upside should momentum shift. Management’s recent capital allocation strategy—prioritising R&D and strategic acquisitions—positions the company to capture emerging market segments, potentially nudging the share price toward its 2026 high.
Investors should monitor the next earnings cycle for indications of revenue acceleration and margin expansion. Should the broader European equity environment remain accommodative, Reploid’s intrinsic valuation could translate into a tangible upside for long‑term stakeholders.